Moderna stock tumbled after the Senate Finance Committee voted to send RFK Jr.'s nomination for the HHS secretary to the full chamber.
The FDA is mired in uncertainty with some staffers losing their jobs over the weekend and more potentially to come, vaccines ...
According to HHS, the funding will enable Moderna to streamline a vaccine that is “well matched to strains currently circulating in cows and birds,” and expand data on the use of mRNA vaccines ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about 72 ...
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...
Without further ado, let's jump right in. The U.S. Department of Health and Human Services (HHS) had already granted Moderna another $176 million back in July 2024. This is mostly focused on the ...
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
There is also concern about how Moderna will operate under a new administration in Washington with the confirmation of Robert F. Kennedy Jr. at the helm of the Health and Human Services (HHS ...